Product Information
TERIFLUNOMIDE 14 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2415 per EA under NDC 59651005530. Its NADAC has been published 153 times since Sep 20, 2023.
FDA first approved this application on Oct 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
14 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651005530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERIFLUNOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209638FDA Approved
10/26/2018
TE Code
AB
On Market Since
2/28/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIFLUNOMIDE 14 MG TABLET has been published 153 times since Sep 20, 2023, and over the history we have for it it has declined 73.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2415 per EA |
|---|---|
| All-time high | $0.9109 (Oct 11, 2023) |
| All-time low | $0.2415 (Aug 19, 2026) |
| 52-week high | $0.7383 |
| 52-week low | $0.2415 |
| Median price | $0.6934 |
| Average price | $0.6671 |
| Largest weekly change | +63.1% (Aug 21, 2024) |
| Weeks tracked | 153 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERIFLUNOMIDE 14 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 14 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2415 per EA (NDC 59651005530), effective Aug 19, 2026.
How has the price of TERIFLUNOMIDE 14 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERIFLUNOMIDE 14 MG TABLET has declined 73.5%. It has been tracked across 153 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 14 MG TABLET?
Since Sep 20, 2023, the NADAC for TERIFLUNOMIDE 14 MG TABLET has ranged from a low of $0.2415 (Aug 19, 2026) to a high of $0.9109 (Oct 11, 2023), with a median of $0.6934 per EA.
Are there cheaper alternatives to TERIFLUNOMIDE 14 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIFLUNOMIDE 14 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERIFLUNOMIDE 14 MG TABLET?
TERIFLUNOMIDE 14 MG TABLET (NDC 59651005530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.